Application Nr Approved Date Route Status External Links
NDA203314 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Tresiba Is Indicated To Improve Glycemic Control In Patients 1 Year Of Age And Older With Diabetes Mellitus. Limitations Of Use O Not Recommended For The Treatment Of Diabetic Ketoacidosis. Tresiba Is A Long-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Patients 1 Year Of Age And Older With Diabetes Mellitus ( 1 ). Limitations Of Use: • Not Recommended For Treating Diabetic Ketoacidosis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Degludec

Comments